hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
复制标题
DOI:
10.1073/pnas.1715998115
复制
发表时间:
2018-03-20
影响因子:
11.1
通讯作者:
Rosanò L
中科院分区:
文献类型:
--
作者:
Di Modugno F;Caprara V;Chellini L;Tocci P;Spadaro F;Ferrandina G;Sacconi A;Blandino G;Nisticò P;Bagnato A;Rosanò L
Discovering new targets and novel determinants of metastatic spread is an unmet need in ovarian cancer, which is plagued by high rates of recurrence. Endothelin-1 receptors (ET-1R), belonging to the G-protein–coupled receptor family, represent important targets critically involved in malignant progression. Here we identify a mechanistic link between ET-1R and the actin regulatory protein hMENA/hMENAΔv6 through the specific interaction with the multifunctional protein β-arrestin1 (β-arr1), which initiates signaling cascades as part of the molecular complex crucial for invadopodial maturation and malignant dissemination. Targeting ET-1R by using macitentan, a Food and Drug Administration-approved antipulmonary arterial hypertension drug, can impair the β-arr1–mediated signaling network controlling ovarian cancer progression and therefore represents a therapeutic option for ovarian cancer patients. Aberrant activation of endothelin-1 receptors (ET-1R) elicits pleiotropic effects relevant for tumor progression. The network activated by this receptor might be finely, spatially, and temporarily orchestrated by β-arrestin1 (β-arr1)–driven interactome. Here, we identify hMENA, a member of the actin-regulatory protein ENA/VASP family, as an interacting partner of β-arr1, necessary for invadopodial function downstream of ET-1R in serous ovarian cancer (SOC) progression. ET-1R activation by ET-1 up-regulates expression of hMENA/hMENAΔv6 isoforms through β-arr1, restricted to mesenchymal-like invasive SOC cells. The interaction of β-arr1 with hMENA/hMENAΔv6 triggered by ET-1 leads to activation of RhoC and cortactin, recruitment of membrane type 1-matrix metalloprotease, and invadopodia maturation, thereby enhancing cell plasticity, transendothelial migration, and the resulting spread of invasive cells. The treatment with the ET-1R antagonist macitentan impairs the interaction of β-arr1 with hMENA and inhibits invadopodial maturation and tumor dissemination in SOC orthotopic xenografts. Finally, high ETAR/hMENA/β-arr1 gene expression signature is associated with a poor prognosis in SOC patients. These data define a pivotal function of hMENA/hMENAΔv6 for ET-1/β-arr1–induced invadopodial activity and ovarian cancer progression.
登录
查看更多内容
DOI:
10.1038/nrm3141
发表时间:
2011-06-23
期刊:
Nature reviews. Molecular cell biology
影响因子:
--
作者:
通讯作者:
--
影响因子:
64.5
作者:
Gertler, FB;Niebuhr, K;Soriano, P
通讯作者:
Soriano, P
影响因子:
8
作者:
Rosano, L.;Cianfrocca, R.;Bagnato, A.
通讯作者:
Bagnato, A.
影响因子:
9.2
作者:
Bravo-Cordero, Jose Javier;Oser, Matthew;Chen, Xiaoming;Eddy, Robert;Hodgson, Louis;Condeelis, John
通讯作者:
Condeelis, John
影响因子:
7.2
作者:
Melchionna R;Iapicca P;Di Modugno F;Trono P;Sperduti I;Fassan M;Cataldo I;Rusev BC;Lawlor RT;Diodoro MG;Milella M;Grazi GL;Bissell MJ;Scarpa A;Nisticò P
通讯作者:
Nisticò P